Clinical Trial Update: Lapatinib Combined With Paclitaxel For Patients With First-Line ErbB2-Amplified Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

This is a Phase 2 trial update reporting results for combining lapatinib with paclitaxel as first-line therapy for ErbB2/amplified metastatic breast cancer; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Lapatinib (Lapatinib)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Breast | Phase 2 | Status: COMPLETED | Results posted: 2014-07-21